ondansetron
Generic: ondansetron
Labeler: a-s medication solutionsDrug Facts
Product Profile
Brand Name
ondansetron
Generic Name
ondansetron
Labeler
a-s medication solutions
Dosage Form
TABLET, ORALLY DISINTEGRATING
Routes
Active Ingredients
ondansetron 4 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50090-1658
Product ID
50090-1658_b108bb68-c81b-48a3-876b-e0280f726a1b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA078152
Listing Expiration
2026-12-31
Marketing Start
2007-06-27
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
500901658
Hyphenated Format
50090-1658
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ondansetron (source: ndc)
Generic Name
ondansetron (source: ndc)
Application Number
ANDA078152 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 4 mg/1
Packaging
- 1 BLISTER PACK in 1 PACKET (50090-1658-0) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
- 1 BLISTER PACK in 1 PACKET (50090-1658-1) / 20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
- 1 BLISTER PACK in 1 PACKAGE (50090-1658-2) / 5 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (50090-1658-3)
Packages (4)
50090-1658-0
1 BLISTER PACK in 1 PACKET (50090-1658-0) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
50090-1658-1
1 BLISTER PACK in 1 PACKET (50090-1658-1) / 20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
50090-1658-2
1 BLISTER PACK in 1 PACKAGE (50090-1658-2) / 5 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
50090-1658-3
30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (50090-1658-3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b108bb68-c81b-48a3-876b-e0280f726a1b", "openfda": {"nui": ["N0000175817", "N0000175818"], "unii": ["4AF302ESOS"], "rxcui": ["104894", "312087"], "spl_set_id": ["5a81a39b-051b-414e-a6b0-d844de4e9ab4"], "pharm_class_epc": ["Serotonin-3 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Serotonin 3 Receptor Antagonists [MoA]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 PACKET (50090-1658-0) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK", "package_ndc": "50090-1658-0", "marketing_start_date": "20150123"}, {"sample": false, "description": "1 BLISTER PACK in 1 PACKET (50090-1658-1) / 20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK", "package_ndc": "50090-1658-1", "marketing_start_date": "20150123"}, {"sample": false, "description": "1 BLISTER PACK in 1 PACKAGE (50090-1658-2) / 5 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK", "package_ndc": "50090-1658-2", "marketing_start_date": "20150123"}, {"sample": false, "description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (50090-1658-3)", "package_ndc": "50090-1658-3", "marketing_start_date": "20170116"}], "brand_name": "Ondansetron", "product_id": "50090-1658_b108bb68-c81b-48a3-876b-e0280f726a1b", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Serotonin 3 Receptor Antagonists [MoA]", "Serotonin-3 Receptor Antagonist [EPC]"], "product_ndc": "50090-1658", "generic_name": "Ondansetron", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ondansetron", "active_ingredients": [{"name": "ONDANSETRON", "strength": "4 mg/1"}], "application_number": "ANDA078152", "marketing_category": "ANDA", "marketing_start_date": "20070627", "listing_expiration_date": "20261231"}